New York Times Feed

HEALTHCARE

Takeda Named Global Top 100 Most Sustainable Corporation for Fifth Year RunningJanuary 22, 2020

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) is proud to be named in the Corporate Knights Global 100 Most Sustainable Corporations in the World (Global 100) for the fifth consecutive year. Corporate Knights assesses more than 7,300 companies against 21 key performance indicators. It uses these indicators to determine the top 1% most sustainable companies in the world, which are announced annually at the World Economic Forum in Davos, Switzerland. “Building sustainable value is a fundamental part of the way we do business at Takeda, and we are proud to be recognized as a global leader in sustainability,” said Christophe Weber, President and CEO. “This recognition by Corporate Knights is a testament to the strong foundation Takeda has laid and the progress we have already achieved. We remain steadfast in our commitment to realizing Better......

Continue Reading >
Japan grants $90,620 to install equipment for charitable medical centre in east AmmanJanuary 21, 2020

AMMAN — The Japanese government has extended a grant of $90,620 to Al Urwah Al Wuthqa Charitable Association for the provision of medical equipment under the Grant Assistance for Grass-Roots Human Security Projects (GGP) scheme.

The grant contract was signed on Monday by Japanese Ambassador to Jordan Yanagi Hidenao and President of the association Mousa Salman Al Aqtash, according to an embassy statement.

The"...

Continue Reading >
Gov't okays licensing of 3 private medical universitiesJanuary 20, 2020

Amman, Jan. 19 (Petra) -- The Cabinet on Sunday gave the go-ahead for the licensing of three private medical universities, within specific controls, ensuring that they meet the necessary conditions.

Speaking on the conditions the Cabinet laid out in its meeting today, Minister of Higher Education and Scientific Research, Muhyiddine Touq, said any new private medical university must have a partnership with one of the world's best 500 universities to make available key faculty members in the first five years....

Continue Reading >
ResMed Introduces AirFit F30i, Its First Tube-up Full Face CPAP Mask January 20, 2020

ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit F30i, its first tube-up full face CPAP mask, rounding out the most complete full face mask portfolio on the market.

Full face CPAP users can now choose between a tube-up or tube-down connection, compact under-the-nose or traditional over-the-nose cushion styles, and even memory foam versus silicone cushion.

AirFit F30i’s"...

Continue Reading >
Obesity key to type 2 diabetes, which has quadrupled in the last 35 yearsJanuary 20, 2020

Abdulatif, a 73-year old man suffered from complex diabetes which led to kidney failure. Abdulatif, an Emirati by origin weighed 115 kgs and clearly suffered from obesity, a key factor that led to his condition. Research indicates that more than two billion people are overweight or obese globally. Obesity is a major factor for the lead up to type 2 diabetes, which has quadrupled in the last 35 years, and more than 460 million adults in the world now have diabetes. In the UAE, over 64 percent of the population suffers from"...

Continue Reading >
Measures to address hurdles to pharmaceutical industry January 19, 2020

Amman, Jan 18 (Petra) –– Health Minister Saad Jaber said on Saturday that the Jordanian pharmaceutical industry is of a fine quality, which provided it access to over 65 markets worldwide.

He said during a tour of the Joswe Medical and Dar Al Dawa companies that the government would provide support to the pharmaceutical industry to increase its contribution to the national economy, cover the Kingdom's health sector needs and enhance its ability to export Jordanian medicine.

The minister"...

Continue Reading >
Tej Kohli Foundation Moves One Step Closer to the Regeneration of Corneal Tissue to Cure Blindness January 18, 2020

The Tej Kohli Foundation has moved one step closer to a non-surgical treatment for corneal blindness as it prepares to enter into a collaboration with researchers in Montreal, Canada and Moorfields Eye Hospital, UK to develop the Foundation’s recently acquired proprietary technology into an injectable biosynthetic ‘glue-filler’.

The biosynthetic solution is a liquid form that sets as a gel at body temperature and which can then"...

Continue Reading >
Mundipharma Enters Partnership With Samsung Bioepis to Expand Biosimilars Into Hong Kong and TaiwanJanuary 17, 2020

Mundipharma today announced a partnership with Samsung Bioepis to commercialize Samsung Bioepis’ first-wave biosimilar candidates in Taiwan and Hong Kong.

The partnership covers Samsung Bioepis’ biosimilar candidates in the field of immunology and oncology, including SB5 (adalimumab), SB4 (etanercept), SB3 (trastuzumab), and SB8 (bevacizumab).

Through the partnership,"...

Continue Reading >
Takeda to Outline Progress on Business Transformation and Priorities at the 38th Annual J.P. Morgan Healthcare ConferenceJanuary 15, 2020

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) will provide an update on the progress of its business transformation and priorities today at the 38th Annual J.P. Morgan Healthcare Conference. President and Chief Executive Officer, Christophe Weber, will share details on Takeda’s portfolio and pipeline strategy, financial outlook, and ongoing sustainability efforts, including its newly established commitment to carbon neutrality across its value chain. “Last year was an important and successful year for Takeda as we accelerated our transformation to become a leading global biopharmaceutical company,” said Mr. Weber. “Our commitment to bringing better health and a brighter future to patients worldwide continues as we expand our global brands and advance our next-generation pipeline, driving sustainable growth. We also recognize that......

Continue Reading >
Covetrus Enters Into Definitive Agreement to Divest scil animal care to HeskaJanuary 15, 2020

Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that it has entered into a definitive agreement to sell its scil animal care business (“scil”) to Heska Corporation (“Heska”) (NASDAQ: HSKA) for a purchase price of $125 million in cash, subject to customary closing adjustments.

The transaction is expected to close in the next 60 to 90 days, subject to customary closing conditions."...

Continue Reading >